Icahn School of Medicine at Mount Sinai
New York, 10029, United States
NCT Number: NCT00619463
The purpose of the study is to determine the efficacy of aerobic exercise for improving cognition, mood, and fatigue after Traumatic Brain Injury (TBI) as well as examine the role of Brain Derived Neurotropic Factor (BDNF) and peripheral Vascular Endothelial Growth Factor (VEGF) as mediators of response to exercise.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
New York, 10029, United States
The cognitive, emotional and physical effects of TBI are well documented in the literature. Specifically, reduced cognitive functioning and depression, which are much more prevalent than in the general population, represent key challenges in the rehabilitation of persons recovering from TBI. Aerobic exercise has been shown to improve cognition and mood in the general population. Although the positive effects of exercise have been known for some time, only recently have some of the mechanisms underlying these effects been defined. One hypothesized mechanism was that exercise elevates the levels of BDNF and VEGF in the CNS. Although research examining the effects of aerobic exercise in individuals with TBI is limited, exercise has been effective in improving cognition and depression in individuals with other medical conditions, such as cancer, multiple sclerosis, fibromyalgia, dementia, chronic fatigue syndrome, chronic obstructive pulmonary disease and the elderly.
The effects of aerobic exercise on patients with TBI will be examined in this clinical trial, using a crossover design with a wait-list control. The classic crossover design has been modified to examine the effects of an additional 8 weeks of exercise, for a total 16-week intervention, in one group. Participants will be randomized into one of two conditions: Group A - immediate eight weeks of intervention followed by monitoring or Group B - monitoring followed by 8 weeks of intervention. In addition, the participants in Group B will serve as their own controls to determine if another 8 weeks of exercise, for a total of 16 weeks, is necessary for cognitive improvement.
Each person will undergo individual interviews and testing/ questionnaires aimed at measuring cognition, mood, fatigue, and life satisfaction. Blood will be drawn 2 or 3 times to monitor BDNF and VEGF levels. Assessment of cognition, mood, fatigue and life satisfaction will occur at four time points for both groups.
It is hypothesized that aerobic exercise will result in improved cognition and mood from both subjective and objective perspectives. In addition, we will explore the effect of post-TBI exercise on community participation and life satisfaction and explore personal and injury characteristics that mediate effectiveness of aerobic exercise in individuals with TBI.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Eight weeks in an aerobic exercise program- 50 minutes of aerobic exercise on a treadmill - 3 days a week for 8 -16 weeks.
Time frame: Every 8 weeks for 24 weeks
Time frame: Every 8 weeks for 24 weeks
Time frame: Every 8 weeks for 24 weeks
Time frame: Every 8 weeks for 24 weeks
Time frame: Every 8 weeks for 24 weeks
Time frame: Every 8 weeks for 24 weeks
Time frame: Every 8 weeks for 24 Weeks.
Time frame: Every 8 weeks for 24 Weeks.
Time frame: Every 8 weeks for 24 weeks
Time frame: At the beginning of the study. Week 1 of 24
Time frame: At the beginning of the study. Week 1 of 24
Time frame: Every 8 weeks for 24 Weeks
Time frame: Every 8 weeks for 24 Weeks
Time frame: Every 8 weeks for 24 Weeks
Time frame: Once a day
Time frame: Once a week
Icahn School of Medicine at Mount Sinai
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01294332
Behavior, Brain Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT06222502
Behavior, Brain Concussion
Boston, Massachusetts, United States
View Trial DetailsNCT06945835
Behavior, Brain Damage, Chronic
West Hartford, Connecticut, United States
View Trial DetailsNCT06156735
Behavior, Brain Diseases
Malacca, Malaysia
View Trial Details